PDCD1 and neoplasm: Germline genetic aberrations are frequently associated with systemic toxicities as a consequence of anti-tumour agents.10 Hence, we argue that variants of genes involved in the PD-1 pathway are associated with the occurrence of PD-1-inhibitor-induced auto-immune-related toxicities.